Millennium Management
LXRX icon

Millennium Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Millennium Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54,500
Closed -$250K – 7063
2021
Q2 		$250K Buy
+54,500
New +$262K ﹤0.01% 5873

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's LXRX Position: Q1 2026 in Review

Millennium Management increased its Lexicon Pharmaceuticals (LXRX) stake by 2.6% in Q1 2026, buying an estimated $179K and bringing the position to 4,944,731 shares worth $7.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

Millennium Management first reported a position in LXRX in Q4 2014 and has held it in 41 quarters since. The position peaked at $12.9M in Q1 2016. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Millennium Management held 4,944,731 shares of Lexicon Pharmaceuticals worth $7.71M as of Q1 2026.
  • Millennium Management bought 122,998 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $179K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2442 holding.
  • Millennium Management first reported a position in Lexicon Pharmaceuticals in Q4 2014 and has held it in 41 quarters since.
  • Millennium Management's Lexicon Pharmaceuticals position peaked at $12.9M in Q1 2016.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.